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Abstract 
According to the screening data of newborns in the Belgorod region (2006 - 2013) the article determined the frequencies of 
hereditary metabolic diseases in order to establish the need for pharmacotherapy. The frequency of phenylketonuria (PKU) 
among newborns made 1:7831, cystic fibrosis (MV) - 1: 12103, congenital hypothyroidism (CH) - 1:4930, adrenogenital 
syndrome (AGS) - 1:13313, galactosemia (GAL) - 1:33284. There are 58 children with hereditary metabolic diseases and 
the need of pharmacotherapy in the Belgorod region (2006 - 2013). 
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Introduction 
Currently, there are numerous modern data on the 
prevalence, clinic, diagnosis, including prenatal and 
neonatal, of frequently occurring hereditary diseases 
(HD), the study period for prenatal diagnosis and the 
obtained data interpretation. Despite the results of 
complex medical and population genetic studies of 
hereditary diseases among children [10, 11], the 
problem of early diagnosis, pharmacotherapy and HD 
prevention has not been resolved fully. It should be 
noted that the population-genetic aspects of these 
diseases have been studied only in certain regions of 
Russian Federation, although the development of HD 
genetic epidemiology issue is of fundamental 
importance both from practical and theoretical point 
of view.  
Modern pharmacogenetics seeks to identify genes 
and their variants that determine the adequacy of 
pharmacotherapy and reduce the risk of side effects 
[6, 27, 28]. Nowadays they determined the 
associations of polymorphisms of several candidate 
genes with the development of the most common 
multifactrial diseases [9, 13, 14, 15, 22, 23] and 
showed the genetic determination of congenital and 
chromosomal diseases [8, 21, 24]. Significant 
advances in the development of molecular genetic 
testing methods and technologies allow in most cases 
to carry out molecular genetic diagnostics of some HD 
successfully. The greatest difficulty is the evaluation 
of the contribution to the development of rare and 
previously unidentified disease mutations, as well as 
the determination of genotype-phenotype relationship 
and the influence of modifier genes on the disease 
severity. 
Recently, the interest in hereditary metabolic 
diseases (HMD) has been increased. Hereditary 
metabolic diseases include more than 700 nosological 
forms. These diseases are associated with the 
disorders of a particular metabolic pathway. These 
include: phenylketonuria (PKU), congenital 
hypothyroidism (CH), galactosemia (GAL), 
adrenogenital syndrome (AGS) and cystic fibrosis 
(CF). These diseases are related to such pathologies in 
which timely initiated treatment can prevent the 
development of serious diseases and severe 
disabilities, as well as reduce the economic costs 
associated with pharmacotherapy, social rehabilitation 
and life support for disabled people. For several 
decades, mass screening and selective screening 
programs have been used for the purpose of HMD 
early detection. However, it should be noted that the 
population-genetic aspects of these diseases were 
studied only in certain regions of Russian Federation 
[1-4, 7, 12, 18, 19, 25, 26]. 
The results of phenylketonuria monitoring among 
children and adolescents in the Sverdlovsk Region 
showed that a pronounced economic effect is achieved 
with the implementation of the mass screening 
program, i.e. the total cost of screening tests and 
treatment is several times less than the cost of 
maintaining undiagnosed patients who are disabled. 
According to foreign authors, the ratio of the 
economic benefit from the saved work capacity to the 
funds spent on the screening program and the 
treatment of patients is from 1.8 to 7.9 for PKU (Work 
summary ..., 2005). The economic efficiency of 
neonatal screening for Russia, calculated according to 
the State Statistics Committee data, makes 3.74, 
taking into account 90% of identified sick children. 
Journal of International Pharmaceutical Research, ISSN: 1674-0440 248 
 
 
With the increase of identified patient percentage to 
100%, the efficiency increases up to 4.33 [20]. 
In accordance with the mentioned above, this 
article analyzes the epidemiology of hereditary 
metabolic diseases to determine the need for 
pharmacotherapy among the newborns in the 
Belgorod region. 
Materials and Methods 
They analyzed the most common hereditary 
metabolic diseases (HMD): phenylketonuria (PKU), 
congenital hypothyroidism (CH), adrenogenital 
syndrome (AGS), cystic fibrosis (CF) and 
galactosemia (GAL). In order to analyze the incidence 
rates among the Belgorod region population (21 
districts), the birth rate data were obtained for the 
period from 2006 to 2013 (the data from the statistics 
department of the Belgorod region) and the data on 
the number of children born with a hereditary 
metabolic pathology (the data from the regional 
medical genetic consultation). 
Results and Discussion 
They began to introduce neonatal screening for 
PKU and congenital hypothyroidism on the territory 
of Belgorod region since 1984 with medical genetic 
consultation, and in 2016 they included galactosemia, 
adrenogenital syndrome, and cystic fibrosis to the 
screening program. 
Phenylketonuria is monogenic, autosomal 
recessive disorder, the most common among HMD 
from the group of aminoacidopathies. According to 
the mass screening of newborns in different countries 
the frequency of PKU makes 1: 10,000 on average, 
but varies considerably depending on population 
(from 1:4500 in Ireland to 1:10,000 in Finland, and it 
was not revealed among the Polynesians). The 
prevalence of PKU in Russia is 1 case per 7000-10000 
of newborns. During the period from 2006 to 2013 
they recorded 17 cases of PKU among 133134 infants 
of the Belgorod region (Table 1). The frequency of 
PKU among the newborns of the Belgorod region 
makes 1:7831 on the average, which is comparable 
with the data for Russia. The maximum number of 
PKU patients in the Belgorod region was recorded in 
2006, as well as in 2012 and 2013 (3 cases each). 
There were no cases of PKU children in 2010 (Table 
1). The analysis of PKU territorial distribution in the 
regional populations of the Belgorod region showed 
that the maximum values of PKU frequency during 
the study period were noted in Valuisky (1: 1862), 
Borisovsky (1:2322), Krasnogvardeisky (1:3015), 
Rakityansky (1:3221) districts, the minimum ones 
were recorded in Starooskolsky (1:23051), Belgorod 
(1:8261) and Shebekinsky (1:7308) districts. In other 
areas no PKU cases have been reported during the 
period of 2006-2013. They established the 
relationship between PKU incidence and the value of 
random inbreeding, calculated by us earlier [16, 17], 
among the Belgorod region population. Spearman 
correlation coefficient between PKU frequency and 
subdivision level was ρ = 0.5 (p < 0.05). 
Table-1: The number of children born with hereditary metabolic disorders among newborn children in the 
areas of the Belgorod region (206-2013) 
Studied populations 
(rural municipality) 
N
um
be
r o
f 
bi
rth
s 
PKU CH AGS CF GAL fr * 
Alekseevsky 5180  1    0.00028 
Belgorodsky 8520 4  2 1 1 0.00003 
town of Belgorod 26909 1 5  2 2 - 
Borisovsky 1998 1 3    0.00022 
Valuisky 5242 3 1 2 1  0.00015 
Weidelevsky 1754  2    0.00033 
Volokonovsky 2496   1   0.00024 
Grayvoronsky 2176   1 1  0.00029 
Gubkinsky 8262 2 1 2   0.00019 
Ivnyansky 1762  1  1  0.00048 
Korochansky 2857  1  1  0.00022 
Krasnensky 829      0.00125 
Krasnogvardeysky 3015 1   1  0.00025 
Krasnoyaruzhsky 1331      0.00052 
Novooskolsky 3067      0.00019 
Prokhorovsky 2160      0.00039 
Rakityansky 2810 1 1  1  0.00029 
Ровенской 2073    1  0.00062 
Starooskolsky 19905 1 1    0.00007 
town of Stary Oskol 17628 2 4   1  
Chernyansky 2731  1    0.00025 
Shebekinsky 7308 1 3 1   0.00016 
Yakovlevsky 4486  2 1 1  0.00009 
Total 133134 17 27 10 11 3 0.00031 
Notes: PKU – phenylketonuria, CH – congenital hypothyroidism, AGS – adrenogenital syndrome, CF – cystic 
fibrosis, GAL–galactosemia 
Journal of International Pharmaceutical Research, ISSN: 1674-0440 249 
 
 
 
 
Congenital hypothyroidism is conditioned by 
complete or partial dysfunction of the thyroid gland. 
According to the literature, in 80-85% of cases 
inheritance is sporadic. In the remaining 15-25% of 
cases, it is inherited by autosomal way and 
recessively. The mass screening of newborns for CH 
has been carried out in the Belgorod Region since 
1993. Among 133,134 of newborns, 27 were 
diagnosed with congenital hypothyroidism. The 
frequency of CH in the region made 1:4930, which 
corresponds to all-Russian values, for which the 
frequency makes 1 case among 3500 - 4100 of 
newborns. The maximum number of patients with CH 
was registered in the Belgorod region during 2010 and 
made 5 cases. The maximum frequency of CH during 
the study period was observed in Borisovsky (1:774), 
Veidelevsky (1:996), Ivnyansky (1:2035), 
Shebekinsky (1:2436), Yakovlevsky (1:2583), 
Korochansky (1:2884), Chernyansky (1:3107) and 
Rakityansky (1:3221) districts. The minimum 
frequency of CH was observed in Starooskolsky 
(1:23051), Gubkinsky (1:9446) and Belgorod (1:8261) 
areas. No cases of CH were registered in other areas 
during the period of 2006-2013. Spearman's 
correlation coefficient between the frequency of CH 
and the level of division amounted to ρ = 0.5 (p < 
0.05). 
Adrenogenital syndrome (AGS) (congenital 
adrenal hyperplasia, Wilkins syndrome) is THE group 
of diseases based on THE defect in one of enzymes or 
transport proteins involved in cortisol biosynthesis of 
the adrenal cortex. The mass screening of newborns 
for adrenogenital syndrome has been carried out in the 
Belgorod region since 2006. This disease is inherited 
as autosomal recessive type. The frequency of AGS 
among the newborns of the Belgorod region for the 
period from 2006 to 2013 was 1:13313. The 
maximum number of patients with AGS in the 
Belgorod region was registered in 2006 - 3 cases. 
There were no cases of children born with AGS in 
2008, 2009 and 2011. The maximum frequencies of 
AGS (1:3369) are observed in Valuisky, 
Volokonovsky, Grayvoronsky, Gubkinsky, 
Shebekensky and Yakovlevsky areas, and the 
minimum ones (1:15653) in Belgorod area. There are 
no cases of AGS in other areas during the studied 
period. 
Cystic fibrosis (CF) is the hereditary disease 
characterized by multiple organ disorders, with the 
primary lesion of endocrine glands, 
bronchopulmonary and digestive systems, 
characterized by early manifestation, short life 
expectancy of patients, the course and prognosis 
severity. This disease is inherited by autosomal 
recessive type. During the period from 2006 to 2013 
the frequency of CF among the newborns of the 
Belgorod region was 1: 12103, which is comparable 
with the data for Russia. The maximum number of 
patients with CF in the Belgorod region was registered 
in 2007 — 4 cases, there were no cases of children 
born with CF in 2006 and 2011. Over the past eight 
years, Greivoronsky, Ivnyansky, Korochansky, 
Krasnogvardeisky, Rakityansky and Rovensky 
districts are characterized by the maximum values of 
CF frequency (1:2354), and Belgorod, Valuysky and 
Yakovlevsky districts are characterized by the lowest 
values of CF frequency (1:10417). No cases of CF 
were registered in the remaining areas during the 
study period. 
Since 2006 they have been conducting the 
screening of newborns for galactosemia (GAL) in the 
Belgorod region. Galactosemia is the hereditary 
disease caused by enzyme system defect involved in 
galactose metabolism, accompanied by the 
accumulation of abnormal carbohydrate metabolism 
products in a body causing severe damage to liver, 
nervous system, eyes and other organs. This disease is 
inherited by autosomal recessive type. The frequency 
of GAL was 1:33284 among the newborns of the 
Belgorod region during the period from 2006 to 2013. 
The maximum frequency of GAL (1: 13769) is in the 
Belgorod district, and the minimum one (1:23051) is 
in the Starooskolsky district. No cases of GAL were 
recorded in the remaining areas during the study 
period.  
Conclusion 
Thus, 58 newborns with hereditary metabolic 
diseases (phenylketonuria, cystic fibrosis, congenital 
hypothyroidism, adrenogenital syndrome, 
galactosemia) needing appropriate pharmacotherapy 
have been identified after the study in the Belgorod 
region from 2006 to 2013. The frequency of PKU, 
CH, CF and GAL among the newborns in the region 
is comparable to the average Russian data, while the 
frequency of AGS is lower than in Russian 
populations and comparable to the frequencies of the 
European population. 
References 
1. Amelina M.A., Zinchenko R.A., Stepanova A.A., Gundorova 
P., Polyakov A.V., Amelina S.S., 2016. The study of genotype 
and phenotype relationship(RAS) among the patients with 
phenylketonuria in Rostov region. Medical genetics, 15 
(6(168)): 3-10. (In Russian) 
2. Dedov I.I., Bezlepkina O.B., Vadina T.A., Baibarina E.N., 
Chumakova O.V., Karavaeva L.V., Bezlepkin A.S., Peterkova 
V.A., 2018. The screening for congenital hypothyroidism in 
Russian Federation. The issues of endocrinology, 64 (1): 14-
20. (In Russian) 
3. Gundorova, P., Zinchenko, R.A., Kuznetsova, I.A., Bliznetz, 
E.A., Stepanova A.A., Polyakov A.V., 2018. Molecular-
genetic causes for the high frequency of phenylketonuria in 
Journal of International Pharmaceutical Research, ISSN: 1674-0440 250 
 
 
the population from the North Caucasus. PLoS ONE, 13 (8): 
e0201489.  
4. Gundorova, P., Zinchenko, R.A., Polyakov, A.V., Makarov, 
A.K., 2017. The spectrum of mutations in the PAH gene in 
patients with hyperphenylalaninemia from the Karachay-
Cherkess republic. Russian Journal of Genetics, 53. (7): 813-
819.  (In Russian) 
5. The results of child and mother health care service work in the 
Sverdlovsk region (2004). Ministry of Healthcare of the 
Sverdlovsk region - Ekaterinburg, 2005, - 50 p. (In Russian) 
6. Kondratieva E.I., Novoselova O.G., Petrova N.V., Chakova 
N.I., Bobrovnichy V.I., Krasko O.V., Budzinskiy R.M., 
Zinchenko R.A., Kutsev S.I., 2018. The possibilities of 
clinical pharmacogenetics during the personalized use of 
antibacterial drugs from cystic fibrosis in clinical practice. 
Bulletin of Roszdravnadzor. 3: 68-76. (In Russian) 
7. Devshree Pathak. "Novel Concept of Drug Delivery Based on 
Chronotherapy: A Review." International Journal of 
Pharmacy Research & Technology 4.2 (2014), 23-27.  
8. Suresh, G., Narayana, K.L., Kedar Mallik, M., Srinivas, V., 
Jagan Reddy, G.“ Processing& characterization of 
LENS™deposited Co-Cr-W alloy for bio-medical 
applications”, (2018) International Journal of Pharmaceutical 
Research, 10 (1), pp. 276-285 
9. Litovkina, O., Nekipelova,E., Dvornyk ,V., Polonikov, A., 
Efremova, O., Zhernakova, N., Reshetnikov, E., Churnosov, 
M., 2014. Genes involved in the regulation of vascular 
homeostasis determine renal survival rate in patients with 
chronic glomerulonephritis. Gene, 546 (1): 112-116.  
10. Özer G. The impact of serum vitamin D concentration on 
median nerve conduction. J Clin Exp Invest. 2018;9(2):63-6.  
11. Nasledstvennye bolezni v populyatsiyakh cheloveka 
(Hereditary Diseases in Human Populations), 2002. Ginter, 
E.K., Ed., Moscow: Meditsina.  
12. Novikov P.V., Khodunova A.A., 2012. The first results of the 
extended neonatal screening for hereditary metabolic diseases 
in Russian Federation. Russian Bulletin of Perinatology and 
Pediatrics, 57 (5): 5-12.  
13. Polonikov, A.V., Bulgakova, I.V., Freidin, M.B., Churnosov, 
M.I., Solodilova M.A., Shvetsov Y.D., Ivanov, V.P., 2017. A 
comprehensive contribution of genes for aryl hydrocarbon 
receptor signaling pathway to hypertension susceptibility. 
Pharmacogenetics and Genomics,  27 ( 2): 57-69. 
14. Ponomarenko I.V., Polonikov A.V., Churnosov M.I., 2018. 
Polymorphic loci of LHCGR gene associated with the 
development of uterine myoma. Obstetrics and Gynecology, 
(10): 86-91.  
15. Reshetnikov, E.A., Akulova, L.Y., Dobrodomova, I.S., 
Dvornyk, V.Y.,  Polonikov, A.V., Churnosov, M.I., 2015. The 
insertion-deletion polymorphism of the ACE gene is 
associated with increased blood pressure in women at the end 
of pregnancy.  JRAAS - Journal of the Renin-Angiotensin-
Aldosterone System, 16 (3): 623-632. 
16. Sorokina, I.N., Churnosov, M.I., Balanovska, E.V., 2007a. 
The gene pool of the Belgorod oblast population: I. 
Differentiation of all district populations based on 
anthroponymic data. Russian Journal of Genetics, 43(6): 697-
704.  
17. Sorokina, I.N., Churnosov, M.I., Balanovska, E.V., 2007b. 
The gene pool of the Belgorod oblast population: II. "Family 
name portraits" in groups of districts with different degrees of 
subdivision and the role of migrations in their formation. 
Russian Journal of Genetics, 43(8): 929-936.  
18. Sorokman, T.V., Popeliuk, N.O., 2017. Congenital 
hypothyroidism in children: the intellectual development and 
psychosocial adaptation. Modern Pediatrics. 4 (84): 107-111.  
19. Stavtseva S.N., Kolesnikova Yu.G., Zubtsova T.I., Kirsanova 
V.A., Andreeva N.I., 2018. Adrenogenital syndrome. 10 years 
of screening in Oryol region. Results. The Journal of Scientific 
Articles. Health and Education in the 21st Century, 20 (3): 
84–88.  
20. Stepanov S.S., 2004. Diagnosis of intelligence by drawing test 
method. M.: TC Sfera. 96 p.  
21. Vorsanova, S.G., Yurov, Yu.B., Demidova, I.A., Kolotiy, 
A.D., Kurinnaya, O.A., Krave, V.S., Yurov, I.Yu., 2018. 
Biomarkers for childhood nonmalignant brain diseases 
associated with chromosome instability. Research Result. 
Medicine and Pharmacy, 4(2): 8-17. 
22. Yarosh, S.L., Kokhtenko, E.V., Starodubova, N.I., Churnosov, 
M.I., Polonikov, A.V., 2013. Smoking status modifies the 
relation between CYP1A1*2C gene polymorphism and 
idiopathic male infertility: The importance of gene-
environment interaction analysis for genetic studies of the 
disease.  Reproductive Sciences, 20 (11): 1302-1307. 
23. Mohammadi N, Gupta R. Investigation of Emulgen Possibility 
of Piroxicam and Developing of the Method. Medbiotech 
Journal. 2017;01(02):73-8. 
24. Salah M, Jonbu S. Investigation of Verpamil Effect as 
Adjuvant Anaesthetic Drug. Medbiotech Journal. 
2017;01(01):42-7. 
25. Mirzaei B. Investigation of Antibacterial Effects of Medicinal 
Plants on Bacterial Pathogens of Patients. Medbiotech 
Journal. 2017;01(02):85-9. 
26. Al Jamal A, Al Yousef M. Phytochemical Analysis of Some 
Herbal Medicines. Medbiotech Journal. 2018;02(03):82-4. 
27. Tasnim T, Farasat A. The Bioproduction of Ethanol through 
Isolation of Some Local Bacteria. Medbiotech Journal. 
2018;02(03):132-5. 
28. Jahagirdar, V. L., Davane, M. S., Aradhye, S. C., & Nagoba, 
B. S. (2018). Candida species as potential nosocomial 
pathogens--A review. European Journal of General Medicine, 
15(2). 
Journal of International Pharmaceutical Research, ISSN: 1674-0440 251 
 
